
Paras Healthcare Targets Massive Bed Capacity Surge to 3,011 Amid Disciplined Growth Strategy
IPO-bound Paras Healthcare Ltd has unveiled an aggressive yet financially disciplined growth trajectory, planning to increase its bed capacity by approximately 36 percent by March 2028. The hospital chain, which currently operates 2,211 beds as of March 31, 2026, aims to scale up through strategic expansion focused on North India markets with low healthcare penetration and improving economic prospects.The company filed its draft papers for an Rs 1,800 crore Initial Public Offering (IPO) with SEBI in June and is currently awaiting regulatory approval to float the issue. This move underscores the growing investor interest in the high-acuity specialized hospital sector.
##Strategic Expansion Plan Across Northern India
Paras Healthcare plans to achieve its target capacity of 3,011 beds by FY28. The expansion strategy emphasizes disciplined capital deployment and is focused on strengthening market presence in specific underserved regions.
Key to this growth are two major planned projects: the addition of a 300-bed Gurugram II hospital slated for FY27, and a 500-bed hospital project scheduled for FY28 in Ludhiana. Both these significant developments are being executed under long-term lease arrangements, maintaining the firm’s asset-light approach.
##Focus on Capital Efficiency and Asset-Light Model
The company's expansion philosophy is strictly guided by financial return thresholds, balance sheet robustness, and long-term scalability. Instead of relying solely on owning physical assets, Paras Healthcare employs a flexible mix of owned and asset-light models across its network.
Currently, six of the eight hospitals operated by the chain function from leased premises. Furthermore, the network incorporates revenue-sharing arrangements and Public-private Partnership (PPP) models to optimize operational costs and increase efficiency. As of March 31, the capital expenditure reported stood at Rs 7.63 million per bed.
##Optimized Design Drives Financial Discipline
To ensure maximum financial returns while expanding capacity, Paras Healthcare has placed a strong emphasis on highly optimized hospital design. This includes a greater proportion of shared rooms and compact administrative areas.
The firm is proactively outsourcing non-core services, such as laundry and transport, to uphold its commitment to capital efficiency. This combination of specialized care focus and asset-light growth model is intended to support scalable operations while maintaining strict financial discipline across the network.
##Specialty Care Drives Revenue Growth
A core strength of Paras Healthcare lies in its high-acuity specialties portfolio. Cardiac sciences, oncology, neurosciences, gastro sciences, orthopaedics, sports injury, and renal sciences are critical components of its revenue generation strategy.
The significance of these specialized services is evident in the operating data. These high-acuity departments contributed 74.70 percent of total revenue in FY26, up from 71.92 percent in FY25 and 72.34 percent in FY24. This sustained focus on specialized medicine remains central to its growth narrative.
##IPO Structure and Fund Utilization
The proposed IPO structure includes a fresh issue of equity shares aggregating up to Rs 500 crore, alongside an Offer For Sale (OFS) of equity shares valued at up to Rs 1,300 crore by the existing selling shareholder. The hospital chain operates under the Paras Health brand across five states and one Union Territory.
The proceeds generated from the fresh issue will be strategically utilized. This includes prepayment or repayment of outstanding borrowings, investment into its wholly-owned subsidiary PMHPL for debt servicing, and general corporate purposes.
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.